UAB’s Cancer Center, GO2 Foundation for Lung Cancer initiate STRIDES study to increase African American participation in lung cancer trials

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham is partnering with the GO2 Foundation for Lung Cancer in a study—together with Vanderbilt University Medical Center and Augusta University—to determine how to improve participation from Black communities in lung cancer clinical trials.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more

Login